World Psoriasis Day 2025: IFPA Calls to Stop the Domino Effect of Psoriasis

IFPA urges recognition of the close link between psoriasis and mental health — and action to…

CAGE Bio Announces Start of Double-Blind Vehicle-Controlled Clinical Trial of Novel Topical DNA Aptamer Therapy CGB-600 for Vitiligo Treatment

SAN CARLOS, Calif. and DALLAS, Oct. 23, 2025 /PRNewswire/ — CAGE Bio Inc., a clinical-stage biotechnology…

Dr. Steven J. Corwin to Step Down as NewYork-Presbyterian President and CEO in January; NewYork-Presbyterian Executive Vice President and COO Dr. Brian G. Donley Named His Successor

“It’s an honor and privilege to have the opportunity to lead this extraordinary institution, which is…

American Joint Replacement Registry Marks Record Growth, Strengthens Global Collaboration

The newly released 12th Annual Report highlights new data methodology and stronger collaborations shaping the future…

Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Diagnostics and Immuno-Oncology Advances | DelveInsight

The mismatch repair deficiency market is experiencing significant growth, driven by increasing awareness and adoption of…

Elevate Holistics Announces Positive 2025 Medical Cannabis Research — CEO Aspen Noonan Spearheads Patient-Centric Expansion

KANSAS CITY, Mo., Oct. 23, 2025 /PRNewswire/ — Elevate Holistics, a leading telehealth platform dedicated to…

Innovations Stem Cell Center proclamada "Mejor empresa de tratamientos con células madre en 2025" por Life Sciences Review

El cuidado estandarizado de las células madre ofrece resultados medibles, asequibles y que cambian vidas en…

Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

SAN DIEGO, Oct. 23, 2025 /PRNewswire/ — QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in…

HanchorBio Presents Phase 1 HCB101 Clinical Results at FACO 2025 Demonstrating Safety and Early Antitumor Activity

FACO 2025 presentation highlights HCB101’s favorable safety, strong receptor occupancy, and confirmed responses in patients with…

Premera Blue Cross Responds to Conduent Data Security Incident

MOUNTLAKE TERRACE, Wash., Oct. 23, 2025 /PRNewswire/ — Conduent Business Services, LLC (“Conduent”) is a third-party…